Logo Logo
US Afghanistan
Anonymous Sources

Afghan Bounty Scandal Comes at Suspiciously Important Time for US Military Industrial Complex

Archives for juillet 2020

Tearing Down the Idols of Colonialism: Why Tunisia Must Demand a French Apology

A debate is brewing in Tunisia on whether to demand an apology from France for the exploitation and trauma wrought by French colonialism, a move that could preclude a demand for compensation.

Ramzy Baroud
Par Ramzy Baroud
France Tunisia Feature photo

The visit by newly-elected Tunisian President Kais Saied to France on June 22 was intended to discuss bilateral relations, trade, etc. But it was also a missed opportunity, where Tunisia could have formally demanded an apology from France for the decades of French colonialism, which has shattered the social and political fabric of this North

Lire l'article complet

Israel Defense Ministry Launches COVID-19 Voice Test for Americans

A company formed at the behest of the Israeli Ministry of Defense has begun collecting voice data from Americans to detect COVID-19 symptoms through technology with dubious diagnostic value, but highly profitable applications in law enforcement.

Raul Diego
Par Raul Diego
COVID-19 Israel Feature photo

The Israeli Ministry of Defense has launched a project to analyze people's voices and breathing patterns using artificial intelligence (AI) in order to determine if they have COVID-19. The software allegedly listens for detectable "signs of distress," ostensibly from the respiratory effects of the virus. A May 27 report in the Jerusalem Post stated

Lire l'article complet

Public Outcry Follows Gilead Decision to Charge $3000 for COVID Drug that Costs Pennies to Produce

To make matter worse, Remdesivir is a drug that « has had its development costs paid for, in large part, by independent donors like governments and ministries of health in China, the WHO, and the US government.”

Alan Macleod
Par Alan Macleod

California-based pharmaceutical giant Gilead Sciences has announced that a five-day course of its antiviral drug Remdesivir — shown in tests to effectively fight COVID-19 — will cost $3,120 to Americans with health insurance and $2,340 to those on Medicaid. Yet research published in April calculated that the drug could be produced at a profit for

Lire l'article complet